查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541146

2024-2032 年按类型、产品、规模、应用和地区分類的医药精细化学品市场报告

Pharmaceutical Fine Chemicals Market Report by Type, Product, Size, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球医药精细化学品市场规模达1,411亿美元。

精细化学品是指生产数量有限、价格较高的一组纯净且复杂的化学品。它们是在多步骤批量生物技术方法的支持下在多功能工厂中生产的。与特种化学品不同，这些物质是根据其独特的功能特征和特定的分子特性精确累积的。收集后的精细化学品可用作生产硬脂酸镁和明胶等多种医药化学产品的关键剂、稳定剂和溶剂。目前，它们以专有和非专有变体形式在商业上可用。

医药精细化学品市场趋势：

各种神经系统和心血管疾病（包括心律不整、中风、癌症和冠状动脉疾病）的盛行率不断增加，特别是在老年族群中，是推动医药精细化学品市场成长的主要因素之一。据此，一些国家的政府机构采取了有利倡议，推出新型疫苗、药物和药物治疗冠状病毒疾病（COVID-19）和其他几种疾病，这进一步促进了这些药物在全球的广泛采用。 。反过来，这也是市场成长的另一个推动因素。此外，在满足品质标准的同时，执行不同的使用医药精细化学品作为原料生产药品的指南也有助于市场成长。其他因素，例如製药业的大幅扩张、研发 (R&D) 活动投资的增加以及消费者对多种疾病和可用药物选择的认识不断增强，正在为全球市场创造积极的前景。

本报告回答的关键问题

  • 全球医药精细化学品市场有多大？ 2024-2032年全球医药精细化学品市场预计成长率为何？
  • 推动全球医药精细化学品市场的关键因素是什么？
  • COVID-19对全球医药精细化学品市场有何影响？
  • 全球医药精细化学品市场按类型划分是怎样的？
  • 以产品为基础的全球医药精细化学品市场区隔是怎样的？
  • 全球医药精细化学品市场按规模划分如何？
  • 全球医药精细化学品市场有哪些重点区域？
  • 全球医药精细化学品市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球医药精细化学品市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 所有权
    • 市场趋势
    • 市场预测
  • 非专有
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品

  • 活性成分
    • 市场趋势
    • 市场预测
  • 基本构建块
    • 市场趋势
    • 市场预测
  • 进阶中级
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依规模

  • 大分子
    • 市场趋势
    • 市场预测
  • 小分子
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按应用

  • 心血管
    • 市场趋势
    • 市场预测
  • 神经病学
    • 市场趋势
    • 市场预测
  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 呼吸系统
    • 市场趋势
    • 市场预测
  • 胃肠道
    • 市场趋势
    • 市场预测
  • 肌肉骨骼
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd. (Turpaz)
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM NV
    • Lonza Group AG
    • Solvay SA
    • Syntor Fine Chemicals Ltd. (Aceto Corporation)
    • WR Grace and Co. (Standard Industries Inc.)
Product Code: SR112024A5910

The global pharmaceutical fine chemicals market size reached US$ 141.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 233.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, size and application.

Breakup by Type:

Proprietary

Non-proprietary

Breakup by Product:

Active Ingredients

Basic Building Blocks

Advanced Intermediates

Breakup by Size:

Big Molecules

Small Molecules

Breakup by Application:

Cardiovascular

Neurological

Oncological

Respiratory

Gastrointestinal

Musculoskeletal

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report

  • 1. How big is the global pharmaceutical fine chemicals market?
  • 2. What is the expected growth rate of the global pharmaceutical fine chemicals market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical fine chemicals market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • 5. What is the breakup of the global pharmaceutical fine chemicals market based on the type?
  • 6. What is the breakup of the global pharmaceutical fine chemicals market based on the product?
  • 7. What is the breakup of the global pharmaceutical fine chemicals market based on the size?
  • 8. What are the key regions in the global pharmaceutical fine chemicals market?
  • 9. Who are the key players/companies in the global pharmaceutical fine chemicals market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Fine Chemicals Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Size

  • 8.1 Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2023
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players